• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病LRRK2 G2385R风险变异体的病理生理学评估

Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson's disease.

作者信息

Tezuka Toshiki, Taniguchi Daisuke, Sano Mariko, Shimada Tomoyo, Oji Yutaka, Tsunemi Taiji, Ikeda Aya, Li Yuanzhe, Yoshino Hiroyo, Ogata Jun, Shiba-Fukushima Kahori, Funayama Manabu, Nishioka Kenya, Imai Yuzuru, Hattori Nobutaka

机构信息

Department of Neurology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan.

Department of Neurology, Keio University School of Medicine, Tokyo, 160-8582, Japan.

出版信息

NPJ Parkinsons Dis. 2022 Aug 5;8(1):97. doi: 10.1038/s41531-022-00367-y.

DOI:10.1038/s41531-022-00367-y
PMID:35931783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9355991/
Abstract

Missense variants in leucine-rich repeat kinase 2 (LRRK2) lead to familial and sporadic Parkinson's disease (PD). The pathological features of PD patients with LRRK2 variants differ. Here, we report an autopsy case harboring the LRRK2 G2385R, a risk variant for PD occurring mainly in Asian populations. The patient exhibited levodopa-responsive parkinsonism at the early stage and visual hallucinations at the advanced stage. The pathological study revealed diffuse Lewy bodies with neurofibrillary tangles, amyloid plaques, and mild signs of neuroinflammation. Biochemically, detergent-insoluble phospho-α-synuclein was accumulated in the frontal, temporal, entorhinal cortexes, and putamen, consistent with the pathological observations. Elevated phosphorylation of Rab10, a substrate of LRRK2, was also prominent in various brain regions. In conclusion, G2385R appears to increase LRRK2 kinase activity in the human brain, inducing a deleterious brain environment that causes Lewy body pathology.

摘要

富含亮氨酸重复激酶2(LRRK2)中的错义变异会导致家族性和散发性帕金森病(PD)。携带LRRK2变异的PD患者的病理特征有所不同。在此,我们报告一例尸检病例,该病例携带LRRK2 G2385R变异,这是一种主要出现在亚洲人群中的PD风险变异。患者在疾病早期表现为左旋多巴反应性帕金森综合征,晚期出现视幻觉。病理研究显示存在弥漫性路易小体,并伴有神经原纤维缠结、淀粉样斑块以及轻度神经炎症迹象。生化分析表明,去污剂不溶性磷酸化α-突触核蛋白在额叶、颞叶、内嗅皮质和壳核中积累,这与病理观察结果一致。LRRK2的底物Rab10的磷酸化水平升高在各个脑区也很显著。总之,G2385R变异似乎会增加人脑中LRRK2激酶的活性,诱导产生导致路易小体病理改变的有害脑环境。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9101/9355991/af80fecc0318/41531_2022_367_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9101/9355991/6324cbf43d9b/41531_2022_367_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9101/9355991/af80fecc0318/41531_2022_367_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9101/9355991/6324cbf43d9b/41531_2022_367_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9101/9355991/af80fecc0318/41531_2022_367_Fig2_HTML.jpg

相似文献

1
Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson's disease.帕金森病LRRK2 G2385R风险变异体的病理生理学评估
NPJ Parkinsons Dis. 2022 Aug 5;8(1):97. doi: 10.1038/s41531-022-00367-y.
2
Effect of a Leucine-rich Repeat Kinase 2 Variant on Motor and Non-motor Symptoms in Chinese Parkinson's Disease Patients.富含亮氨酸重复激酶2变异体对中国帕金森病患者运动和非运动症状的影响。
Aging Dis. 2016 May 27;7(3):230-6. doi: 10.14336/AD.2015.1026. eCollection 2016 May.
3
[Clinical molecular genetics for PARK8 (LRRK2)].PARK8(LRRK2)的临床分子遗传学
Brain Nerve. 2007 Aug;59(8):839-50.
4
Localization of Parkinson's disease-associated LRRK2 in normal and pathological human brain.帕金森病相关蛋白LRRK2在正常和病理状态下人类大脑中的定位
Brain Res. 2007 Jun 25;1155:208-19. doi: 10.1016/j.brainres.2007.04.034. Epub 2007 Apr 19.
5
The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation.与帕金森病相关的富含亮氨酸重复激酶 2 的 G2385R 变异是一种部分功能丧失的突变。
Biochem J. 2012 Aug 15;446(1):99-111. doi: 10.1042/BJ20120637.
6
The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population.LRRK2 G2385R 变异是韩国人群散发性帕金森病的一个风险因素。
Parkinsonism Relat Disord. 2010 Feb;16(2):85-8. doi: 10.1016/j.parkreldis.2009.10.004. Epub 2009 Oct 23.
7
LRRK2 p.Ile1371Val Mutation in a Case with Neuropathologically Confirmed Multi-System Atrophy.LRRK2 p.Ile1371Val 突变与神经病理学确诊的多系统萎缩相关。
J Parkinsons Dis. 2018;8(1):93-100. doi: 10.3233/JPD-171237.
8
Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.脑源性神经营养因子(BDNF)基因多态性大大增加了富含亮氨酸重复激酶 2(LRRK2)患帕金森病的风险。
Parkinsonism Relat Disord. 2012 Feb;18(2):140-3. doi: 10.1016/j.parkreldis.2011.09.002. Epub 2011 Sep 16.
9
LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies.帕金森病大脑及路易小体局限病例中的LRRK2水平与磷酸化
Mov Disord. 2017 Mar;32(3):423-432. doi: 10.1002/mds.26892. Epub 2016 Dec 2.
10
Leucine-rich repeat kinase 2 colocalizes with alpha-synuclein in Parkinson's disease, but not tau-containing deposits in tauopathies.富含亮氨酸重复激酶2在帕金森病中与α-突触核蛋白共定位,但在tau蛋白病中不与含tau蛋白的沉积物共定位。
Neurodegener Dis. 2008;5(3-4):222-4. doi: 10.1159/000113708. Epub 2008 Mar 6.

引用本文的文献

1
Interpretable Machine Learning for Cross-Cohort Prediction of Motor Fluctuations in Parkinson's Disease.用于帕金森病运动波动跨队列预测的可解释机器学习
Mov Disord. 2025 Aug;40(8):1604-1617. doi: 10.1002/mds.30223. Epub 2025 May 14.
2
Recent advances in targeting LRRK2 for Parkinson's disease treatment.针对帕金森病治疗靶向亮氨酸丰富重复激酶2(LRRK2)的最新进展。
J Transl Med. 2025 Jul 8;23(1):754. doi: 10.1186/s12967-025-06354-0.
3
Parkinsonism in Alzheimer's disease without Lewy bodies in association with nigral neuron loss: A data-driven clinicopathologic study.

本文引用的文献

1
Elevated Urinary Rab10 Phosphorylation in Idiopathic Parkinson Disease.特发性帕金森病患者尿Rab10 磷酸化升高。
Mov Disord. 2022 Jul;37(7):1454-1464. doi: 10.1002/mds.29043. Epub 2022 May 6.
2
LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss.LRRK2 抑制减轻了 TLR2 特异性 α-突触核蛋白引起的神经炎症,并缓解了神经炎症引起的多巴胺能神经元丢失。
Cells. 2022 Mar 2;11(5):861. doi: 10.3390/cells11050861.
3
Autopsy Validation of the Diagnostic Accuracy of I-Metaiodobenzylguanidine Myocardial Scintigraphy for Lewy Body Disease.
无路易小体的阿尔茨海默病合并帕金森综合征与黑质神经元丢失:一项数据驱动的临床病理研究。
Alzheimers Dement. 2025 Mar;21(3):e14628. doi: 10.1002/alz.14628.
4
Comprehensive data for studying serum exosome microRNA transcriptome in Parkinson's disease patients.研究帕金森病患者血清外泌体 microRNA 转录组的综合数据。
Sci Data. 2024 Oct 15;11(1):1128. doi: 10.1038/s41597-024-03909-6.
5
Impairment of the Glial Phagolysosomal System Drives Prion-Like Propagation in a Model of Huntington's Disease.神经胶质溶酶体系统损伤驱动亨廷顿病模型中的朊病毒样传播。
J Neurosci. 2024 May 15;44(20):e1256232024. doi: 10.1523/JNEUROSCI.1256-23.2024.
6
ATP13A2 (PARK9) and basal ganglia function.ATP13A2(PARK9)与基底神经节功能。
Front Neurol. 2024 Jan 5;14:1252400. doi: 10.3389/fneur.2023.1252400. eCollection 2023.
7
Is Glial Dysfunction the Key Pathogenesis of -Linked Parkinson's Disease?胶质细胞功能障碍是路易体相关性帕金森病的关键发病机制吗?
Biomolecules. 2023 Jan 15;13(1):178. doi: 10.3390/biom13010178.
尸检验证 I-间碘苄胍心肌闪烁照相术诊断路易体病的准确性。
Neurology. 2022 Apr 19;98(16):e1648-e1659. doi: 10.1212/WNL.0000000000200110. Epub 2022 Mar 7.
4
Nanobodies as allosteric modulators of Parkinson's disease-associated LRRK2.纳米抗体作为帕金森病相关 LRRK2 的别构调节剂。
Proc Natl Acad Sci U S A. 2022 Mar 1;119(9). doi: 10.1073/pnas.2112712119.
5
Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation.Tau 通过 PQBP1-cGAS-STING 通路激活小胶质细胞,促进大脑炎症。
Nat Commun. 2021 Nov 15;12(1):6565. doi: 10.1038/s41467-021-26851-2.
6
R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils.R1441G 突变而非 G2019S 突变增强了人外周血中性粒细胞中 LRRK2 介导的 Rab10 磷酸化。
Acta Neuropathol. 2021 Sep;142(3):475-494. doi: 10.1007/s00401-021-02325-z. Epub 2021 Jun 14.
7
Structural analysis of the full-length human LRRK2.全长人 LRRK2 的结构分析。
Cell. 2021 Jun 24;184(13):3519-3527.e10. doi: 10.1016/j.cell.2021.05.004. Epub 2021 Jun 8.
8
Peripheral synucleinopathy in Parkinson disease with LRRK2 G2385R variants.帕金森病伴 LRRK2 G2385R 变异的周围神经突触核蛋白病。
Ann Clin Transl Neurol. 2021 Mar;8(3):592-602. doi: 10.1002/acn3.51301. Epub 2021 Feb 1.
9
Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites.LRRK2 磷酸化 Rab 和 Ser910/Ser935 生物标志物位点的多重靶向质谱分析方法的建立。
Biochem J. 2021 Jan 29;478(2):299-326. doi: 10.1042/BCJ20200930.
10
Interferon-γ signaling synergizes with LRRK2 in neurons and microglia derived from human induced pluripotent stem cells.干扰素-γ 信号与 LRRK2 在源自人诱导多能干细胞的神经元和小胶质细胞中协同作用。
Nat Commun. 2020 Oct 14;11(1):5163. doi: 10.1038/s41467-020-18755-4.